Driven by a large diabetic population, continuous economic growth and increasing disposable incomes, the diabetes market - Non-Insulin Anti-diabetics, Insulin and Diabetes Diagnostics is witnessing double digit growth rates.
As the second largest economy of the world, China enjoys pink of health but its affluence is giving rise to another sickness - a rapid increase in a life-style disease called diabetes. With the Chinese population getting richer, fatter and less mobile, there has been a surge in the prevalence of diabetes. With a prevalence rate of around 12 percent in the adult population, China currently represents the diabetes capital of the world.
The rising prevalence of diabetes, however, is catalysing the market for diabetes products in the country. Driven by a continuous economic growth and increasing disposable incomes, the diabetes market - Non-Insulin Anti-diabetics, Insulin and Diabetes Diagnostics is witnessing double digit growth rates and creating lucrative opportunities for global pharmaceutical and diagnostic companies at a time when growth rates in the more developed markets have declined.
IMARC’s new report “China Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics” provides an analytical and statistical insight into the China diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in China. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Chinese diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the Chinese diabetes market in any form.
What we have achieved in this report:
Comprehensive situation analysis of the Chinese diabetes epidemiology and its dynamics:
Focus of the Analysis:
- Historical, current and future prevalence of diabetes in China
- Historical, current and future prevalence of type-1 and type-2 diabetes in China
- Historical, current and future prevalence of diabetes in the urban and rural regions in China
- Historical, current and future prevalence of diabetes among males and females in China
- Historical, current and future prevalence of diabetes among various age groups in China
- Historical, current and future diagnosis rates for diabetes in China
- Historical, current and future drug treatment rates for diabetes in China
Comprehensive situation analysis of the Chinese Oral Antidiabetics market and its dynamics:
Focus of the Analysis:
- Performance of the Oral Antidiabetics market in China
- Performance of key classes
- Performance of key players
- Market outlook
Comprehensive situation analysis of the Chinese Insulin market and its dynamics:
Focus of the Analysis:
- Performance of the Insulin market in China
- Performance of key classes
- Performance of key players
- Market outlook
Comprehensive situation analysis of the Chinese diabetes diagnostics market and its dynamics:
Focus of the Analysis:
- Performance of the diabetes diagnostics market in China
- Market segmentation
- Key players
- Market outlook
To buy the complete report or to get a free sample, please contact:
IMARC Group Asia:
Email: apac@imarcgroup.com
Phone: +91-120-415-5099
IMARC Group North America:
Email: america@imarcgroup.com
Phone: +1-631-791-1145
IMARC Group Europe, Middle East & Africa:
Email: ema@imarcgroup.com
Phone: +44-702-409-7331
To know more please visit: http://www.imarcgroup.com/china-diabetes-market
